• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOSENSE WEBSTER INC CARTO VIZIGO¿ 8.5F BI-DIRECTIONAL GUIDING SHEATH ¿ LARGE; INTRODUCER, CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOSENSE WEBSTER INC CARTO VIZIGO¿ 8.5F BI-DIRECTIONAL GUIDING SHEATH ¿ LARGE; INTRODUCER, CATHETER Back to Search Results
Model Number D138503
Device Problems Delivered as Unsterile Product (1421); Contamination /Decontamination Problem (2895)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/03/2023
Event Type  malfunction  
Manufacturer Narrative
The bwi product analysis lab received the device for evaluation on 28-feb-2023.The analysis has begun but is not completed at this time.When the investigational analysis has been completed, a supplemental 3500a report will be submitted.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster, inc., or its employees that the report constitutes an admission that the product, biosense webster, inc., or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Manufacturer's reference number: (b)(4).
 
Event Description
It was reported that a patient underwent a procedure with a carto vizigo¿ 8.5f bi-directional guiding sheath ¿ large and a sterilization compromised issue occurred.When starting preparation of the material and before opening the carto vizigo¿ 8.5f bi-directional guiding sheath ¿ large, tiny drops of liquid which seems like condensed water were noticed inside the sterile package.It was decided to report the issue and replace the carto vizigo¿ 8.5f bi-directional guiding sheath ¿ large before opening it.The event occurred during sterile processing and during field inspection.There was no patient consequence.The event was assessed as mdr reportable for a sterilization compromised issue.
 
Manufacturer Narrative
It was reported that a patient underwent a procedure with a carto vizigo¿ 8.5f bi-directional guiding sheath ¿ large and a sterilization compromised issue occurred.When starting preparation of the material and before opening the carto vizigo¿ 8.5f bi-directional guiding sheath ¿ large, tiny drops of liquid which seems like condensed water were noticed inside the sterile package.It was decided to report the issue and replace the carto vizigo¿ 8.5f bi-directional guiding sheath ¿ large before opening it.The event occurred during sterile processing and during field inspection.There was no patient consequence.The investigation was completed on 21-apr-2023.A picture was received for evaluation following biosense webster's procedures.According to pictures provided by the customer, drops of foreign material were observed inside the pouch of the vizigo sheath.The customer complaint was confirmed based on the picture received.The product analysis was performed as appropriate in order to find the root cause of the complaint.The device was returned to biosense webster (bwi) for evaluation.Visual inspection of the returned device was performed following bwi procedures.Visual analysis revealed foreign material inside the package.A fourier transform infrared spectroscopy (ft-ir) analysis was performed and the infrared (ir) data reveals that unknown liquid exhibited the chemical composition of fluourosilane base material, presumably a trifluoropropylmethylsiloxane.The source of origin remains unknown.Based on the preliminary investigation performed, it was confirmed that the ¿moisture/humidity¿ reported by the customer could be related to the silicon coating applied to the hemostatic valve surface.This silicone coating is accidentally migrating to the film section of the pouch since it was found where the hemostatic valve is placed inside the packaging.An internal corrective action has been opened to reduce these issues.A device history record was performed for the finished device batch number, and no internal actions were identified.The issue reported by the customer was confirmed.This product issue will be addressed through bwi¿s quality system.As part of biosense webster¿s quality process, all devices are manufactured, inspected, and released to approved specifications.Explanation of codes: -investigation findings: appropriate term/code not available (c22) / investigation conclusions: cause not established (d15) were selected as related to the ¿picture¿ provided.-investigation findings: inappropriate material (c0602) and manufacturing process problem identified (c16) / investigation conclusions: cause traced to manufacturing (d03) / component code: device ingredient or reagent (g01003) were selected as related to the customer¿s reported issue of ¿sterilization compromised¿ biosense webster inc.Analysis finding of the ¿foreign material inside the device packaging¿.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
 
Manufacturer Narrative
If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(6).During an internal review on 31-may-2023, the h6 medical device problem code was corrected from delivered as unsterile product (a020701) to contamination / decontamination problem (a18).In addition, on 01-jun-2023, the product investigation was reopened to clarify/correct the investigation findings which resulted in the following changes/corrections.A picture was received for evaluation following biosense webster's procedures.According to pictures provided by the customer, drops of foreign material was observed inside the pouch of the vizigo sheath.Based on a preliminary investigation performed, it was confirmed that the ¿moisture/humidity¿ reported by the customer could be related to the silicon coating applied to the hemostatic valve surface.This silicone coating is accidentally migrating to the film section of the pouch since it was found where the hemostatic valve is placed inside the packaging.The customer complaint was confirmed based on the picture received.The product analysis was performed as appropriate in order to find the root cause of the complaint.The device was returned to biosense webster (bwi) for evaluation.Visual inspection of the returned device was performed following bwi procedures.Visual analysis revealed foreign material inside the package.A fourier transform infrared spectroscopy (ft-ir) analysis was performed and the infrared (ir) data reveals that unknown liquid exhibited the chemical composition of fluourosilane base material, presumably a trifluoropropylmethylsiloxane.However, based on the preliminary investigation performed, it was confirmed that the ¿moisture/humidity¿ reported by the customer could be related to the silicon coating applied to the hemostatic valve surface.This silicone coating is accidentally migrating to the film section of the pouch since it was found where the hemostatic valve is placed inside the packaging.A device history record was performed for the finished device batch number, and no internal actions were identified.The issue reported by the customer was confirmed.This product issue will be addressed through bwi¿s quality system.As part of biosense webster¿s quality process, all devices are manufactured, inspected, and released to approved specifications.
 
Manufacturer Narrative
If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).The product investigation was reopened to correct the h6.Component code on 22-feb-2024 from device ingredient or reagent (g01003) to packaging (g04094).During an internal review, noted a correction to the 3500a follow-up #2 as the device evaluation completion should have included ¿an internal corrective action has been opened to reduce these issues.¿.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CARTO VIZIGO¿ 8.5F BI-DIRECTIONAL GUIDING SHEATH ¿ LARGE
Type of Device
INTRODUCER, CATHETER
Manufacturer (Section D)
BIOSENSE WEBSTER INC
31 technology drive, suite 200
irvine CA 92618
Manufacturer (Section G)
BIOSENSE WEBSTER INC (IRVINE)
33 technology drive
irvine CA 92618
Manufacturer Contact
kate karberg
31 technology dr
irvine, CA 92618
3035526892
MDR Report Key16475927
MDR Text Key311233434
Report Number2029046-2023-00451
Device Sequence Number1
Product Code DYB
UDI-Device Identifier10846835016260
UDI-Public10846835016260
Combination Product (y/n)N
Reporter Country CodeAU
PMA/PMN Number
K170997
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Other
Type of Report Initial,Followup,Followup,Followup
Report Date 03/15/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/03/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/13/2023
Device Model NumberD138503
Device Catalogue NumberD138503
Device Lot Number00002058
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/28/2023
Is the Reporter a Health Professional? No
Date Manufacturer Received02/22/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured07/13/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
UNKNOWN BRAND SHEATH
-
-